145,291 Shares in MetLife, Inc. (NYSE:MET) Purchased by Transform Wealth LLC

Transform Wealth LLC acquired a new position in shares of MetLife, Inc. (NYSE:METGet Rating) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 145,291 shares of the financial services provider’s stock, valued at approximately $9,123,000. MetLife makes up about 1.4% of Transform Wealth LLC’s investment portfolio, making the stock its 21st largest position.

A number of other institutional investors have also added to or reduced their stakes in the business. New England Professional Planning Group Inc. bought a new position in MetLife during the 1st quarter worth approximately $602,000. Gradient Investments LLC lifted its stake in shares of MetLife by 89.5% in the 2nd quarter. Gradient Investments LLC now owns 449 shares of the financial services provider’s stock valued at $28,000 after purchasing an additional 212 shares during the period. Riverview Trust Co purchased a new position in shares of MetLife in the 1st quarter valued at approximately $36,000. Stonebridge Capital Advisors LLC lifted its stake in shares of MetLife by 91.1% in the 4th quarter. Stonebridge Capital Advisors LLC now owns 535 shares of the financial services provider’s stock valued at $33,000 after purchasing an additional 255 shares during the period. Finally, Cornerstone Advisory LLC purchased a new position in MetLife during the fourth quarter valued at $36,000. 86.53% of the stock is currently owned by institutional investors.

MetLife Stock Performance

Shares of MetLife stock traded down $2.32 on Friday, reaching $61.15. 132,179 shares of the stock were exchanged, compared to its average volume of 4,319,291. The company has a current ratio of 0.13, a quick ratio of 0.13 and a debt-to-equity ratio of 0.39. The business has a fifty day moving average price of $64.62 and a two-hundred day moving average price of $65.60. MetLife, Inc. has a 1-year low of $57.05 and a 1-year high of $73.18. The firm has a market capitalization of $49.73 billion, a PE ratio of 15.79, a PEG ratio of 0.48 and a beta of 1.05.

MetLife (NYSE:METGet Rating) last announced its quarterly earnings data on Wednesday, August 3rd. The financial services provider reported $2.00 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.55 by $0.45. The business had revenue of $18.30 billion for the quarter, compared to the consensus estimate of $16.53 billion. MetLife had a net margin of 5.26% and a return on equity of 12.90%. As a group, research analysts anticipate that MetLife, Inc. will post 7.36 earnings per share for the current fiscal year.

MetLife Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, September 14th. Shareholders of record on Tuesday, August 9th were issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 3.27%. The ex-dividend date was Monday, August 8th. MetLife’s dividend payout ratio is currently 49.75%.

Analysts Set New Price Targets

A number of analysts have commented on the company. Evercore ISI lifted their target price on MetLife to $81.00 in a report on Tuesday, August 9th. Raymond James assumed coverage on MetLife in a report on Wednesday. They issued a “market perform” rating for the company. Barclays set a $75.00 target price on MetLife in a research report on Tuesday, July 19th. Credit Suisse Group boosted their price objective on MetLife from $68.00 to $77.00 and gave the company an “outperform” rating in a research report on Monday, August 22nd. Finally, Morgan Stanley boosted their price objective on MetLife from $79.00 to $83.00 and gave the company an “overweight” rating in a research report on Wednesday, August 17th. Two analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. According to data from MarketBeat, MetLife presently has a consensus rating of “Moderate Buy” and a consensus price target of $76.92.

Insider Transactions at MetLife

In other MetLife news, EVP Steven J. Goulart sold 4,060 shares of the business’s stock in a transaction dated Friday, August 19th. The shares were sold at an average price of $67.60, for a total transaction of $274,456.00. Following the sale, the executive vice president now directly owns 55,299 shares in the company, valued at approximately $3,738,212.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.26% of the company’s stock.

MetLife Profile

(Get Rating)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Further Reading

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:METGet Rating).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.